Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin
NCT00501020
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
750
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Rosiglitazone
Sponsor
GlaxoSmithKline